9/24/20 Leaderboard Pharma


Available from Lifecore Biomedical

Lifecore has licensed the patented Corgel® BioHydrogel technology from the Cleveland Clinic. This biocompatible hyaluronan hydrogel is based on di-hydroxyphenyl linkages of tyramine substituted sodium hyaluronate (NaHy). Lifecore has completed ISO 10993 safety and toxicity studies on this technology.

Corgel® BioHydrogel has a wide range of physical properties depending on the tyramine substitution (TS) percentage and the tyramine substituted hyaluronan (TS-NaHy) concentration. Hydrogels formed from TS-NaHy solutions of 6.25 – 100 mg/mL display a spectrum of physical properties that include those of a weak gel, a paste, or a fractile solid.

Corgel® Kits are available with 1%, 3%, or 5% TS of the NaHy.
Depending on the targeted TS-NaHy concentration, Corgel® Kits yield a total of between 5 and 50mLs.

Rate and Review Lifecore Biomedical

Rating: 0 - 0 reviews
Let users know what you would have wanted to know about this company.
Click on a star to rate this company
  Privacy Policy.
When writing a review, please adhere to the Review Guidelines.